Introduction
Phospholipase D (PLD) catalyses the hydrolysis of phosphatidylcholine to generate phosphatidic acid (PA), a second messenger, and choline (Exton, 1998; Cockcroft, 2001 ). Two main products of PLD genes have been described: PLD1 and PLD2 Park et al., 1997; Lopez et al., 1998; Sung et al., 1999) , as well as their regulators (Powner and Wakelam, 2002) . The expressed proteins contain two invariable sequences: HxK(x)4D(x) 6 GSxN (or HKD), that are responsible for their enzymatic activity; as well as several conserved regions, such as a PIP 2 binding site, a plekstrin-homology (PH) domain and a phox (PX) domain (Sung et al., 1997 (Sung et al., , 1999 Park et al., 2000) .
The PH domain of PLD2 associates with SH2/SH3-containing tyrosine kinases (Ahn et al., 2003; Choi et al., 2004) and the increase in total tyrosine phosphorylation of PLD2 correlates with an apparent increase in PLD activity (Choi et al., 2004) . Whether total tyrosine phosphorylation of PLD2 and its high degree of basal activity are physiologically linked is subject to intense investigation (Bourgoin and Grinstein, 1992) .
Phosphotyrosine motifs serve as docking sites for recruitment of SH2-domain containing proteins like the growth factor receptor bound protein 2 (Grb2) (Schlessinger, 1994) . Grb2 is ubiquitously expressed and entirely composed of two SH3 domains and one central SH2 domain (Lowenstein et al., 1992) . Grb2 binds phosphotyrosine-containing proteins through its SH2 domain, whereas the flanking SH3 domains interact with proline-rich motifs in signaling proteins. The most characterized of such interactions is the activation of the mitogenic Ras via direct interaction of the SH3 domains of Grb2 with the C-terminal proline-rich domain of the Ras guanine-nucleotide exchange factor, Sos, and the consequent stimulation of the MAPK cascade and cellular proliferation Egan et al., 1993) .
As indicated previously by our laboratory, PLD2 exists as a complex with Grb2 and PTP1b (Horn et al., 2005) . Here 179 is negatively involved in cell proliferation through the Ras/MAPK pathway.
Results

Preparation of mutant series
In experiments designed to analyse the interaction PLD2/Grb2, a series of expression plasmids were created. In the case of PLD2 mutants, (Figure 1a ), all the plasmids, which contain a myc tag, were transiently expressed in COS-7 cells followed by analysis of protein expression and lipase enzyme activity. In the case of Grb2 mutants, (Figure 1b) all the plasmids, which contain a GST tag, were expressed in bacteria and the recombinant proteins purified in order to study the effect on PLD2 binding in vitro.
Binding of Grb2 to PLD2 is direct and specific To address if PLD2 directly interacts with Grb2, a GSTfusion protein of human Grb2 and a SH2-deficient Grb2 mutant, R86K, were created and tested for the ability to bind mycPLD2 in in vitro GST-pull-down assays. As shown in Figure 2a , purified GSTGrb2 interacts with mycPLD2. However, neither the SH2-deficient mutant (GSTGrb2 R86K) nor GST alone was able to pull-down mycPLD2 (Figure 2b and c, respectively), suggesting that the SH2 domain of Grb2 binds mycPLD2 in vitro. The specificity of the PLD2/Grb2 interaction was analysed by incubation of Sepharose/GSTGrb2/mycPLD2 complexes with increasing amounts of purified Grb2. As indicated in Figure 2d and inset, purified Grb2 caused an B80% reduction in mycPLD2 bound to Sepharose beads. In conclusion, mycPLD2 specifically interacts with the SH2 domain of Grb2 in vitro.
PLD2 Y
179 is a docking site for Grb2 SH2-mediated interaction of Grb2 is exclusively mediated by a single phosphotyrosine residue at the Figure 1 Schematic nonscale representation of mycPLD2 and GSTGrb2 mutants. (a) The amino-acid residues involved in the creation of mutation and deletion series of mycPLD2 constructs are indicated in light gray together with their relative position (bar at the top). Also indicated are the PX domains and HKD domains. Boxed in the indicated PX domain of mycPLD2 are the sequences of interest used for these studies. (b) The typical SH3-SH2-SH3 domain structure of the fusion protein GSTGrb2 WT is depicted as boxes located C-terminally of the GST tag. The impaired SH2 or SH3 functionality of GSTGrb2 R86K or P49/206L, respectively, are indicated as crossed boxes in their respective SH domains.
Figure 2 PLD2 interacts with Grb2 in vitro. The indicated amounts (in mg) of precleared COS-7 lysates expressing mycPLD2 were incubated with: (a) 1.5 mg purified Grb2, (b) 5 mg R86K or (c) 5 mg GST protein alone. After pull-down, the glutathioneSepharose beads were subjected to SDS-PAGE and derived Western blots were probed with anti-myc and anti-GST antibodies. (d) In vitro binding competition of mycPLD2 to purified Grb2. The pull-down complex Sepharose/GSTGrb2/mycPLD2 was incubated in the presence of increasing amounts of purified Grb2 protein (0, 1, 3 and 5 mg) and analysed for the presence of mycPLD2.
PLD2 docking sites for Grb2 M Di Fulvio et al N-terminal of the YxNx consensus (pYxNx) in the target protein (Songyang et al., 1993 (Songyang et al., , 1994 The selectivity of Grb2 binding is determined by an asparagine (N) at the þ 2 position of the consensus sequence pYxNx, whereas positions À2, À1, þ 1, and þ 3 are not likely to mediate Grb2 binding (Songyang et al., 1993 (Songyang et al., , 1994 It has been demonstrated before that the removal of the first 183 amino acids of PLD2 render the protein inactive in vitro (Sung et al., 1999; Park et al., 2000) . Next, we investigated the role of the Grb2-binding residues Y 169 and Y 179 (that are within those 183 N-end amino acids) in modulating PLD2 lipase activity. As shown in Figures 5a and b, the F replacement of Y 169 was enough to eliminate PLD activity, whereas Y 179 was dispensable for PLD2 catalysis since mycPLD2 Y179F and DY 179 were fully active enzymes. The same substitution of Y 165 had no effect on PLD2 activity, as described earlier (Choi et al., 2004) .
These results establish for the first time a vital role of Y 169 in eliciting the high basal activity observed in PLD2. In order to confirm this, COS-7 lysates overexpressing the fully active mutant mycPLD2 Y179F were immunoprecipitated and total PLD activity analysed in vitro in the presence of competing amounts of GSTGrb2 P49/206L (a SH3-deficient mutant). As shown in Figure 5c , mycPLD2 Y179F dropped its catalytic activity by B70% when GSTGrb2 P49/206L was included in the PLD assay ( Figure 5c ). These results demonstrate that the SH2 domain of Grb2 interacts with Y 169 and suggests that PLD2-Y 169 /Grb2 association is linked to high basal PLD2 activity via the SH3 domains of Grb2.
Once docked to their substrates via SH2, the SH3 domains of Grb2 recruit tyrosine kinases and phosphatases (Schlessinger, 1994) , and tyrosine phosphorylation has been described for PLD2 activity (Houle and Bourgoin, 1999 Binding of Grb2 to PLD2 is independent of enzyme activity Since Y 169 is required for basal PLD2 activity and Grb2 binding, we next examined if PLD2 catalysis and Grb2 binding are related phenomena. To this end, two catalytically inactive mutants, mycPLD2 K444R, K758R and K444/758R, were created and tested for PLD activity in vitro and for their ability to interact with endogenous Grb2 in vivo. As expected, mycPLD2 K444R, K758R and K444/758R mutants were inactive (Figure 6a ). However, no differences between inactive mutants and WT were observed in Grb2 binding (Figure 6b ), indicating that Grb2 recruitment to mycPLD2 is not impaired by deficient PLD activity. As a corollary, neither PA nor any of the PLD2-generated metabolites that might mediate tyrosine phosphorylation of PLD2, seem to be involved in Grb2 binding in vivo.
PLD2 residues Y
169 and Y 179 are involved in Sos recruitment Grb2 exists as a complex with Sos in vivo Egan et al., 1993; Li et al., 1993 , (which bind to Grb2), are responsible for Sos recruitment, and that the complex PLD2/Grb2/Sos exists in vivo. . Protein sequence alignment of the Cterminal of PLD PX domains are shown in light gray and the Y residues subject to this study are depicted in bold. Boxed sequences represent the putative SH2-Grb2 consensus binding sites (b) PLD2/ Grb2 interaction in vivo. COS-7 lysates from cells transiently expressing mycPLD2 WT, Y169F, Y179F or Y169/179F were subjected to immunoprecipitation with anti-Grb2 or anti-myc antibodies. Immunoprecipitates were separated by SDS-PAGE, immunoblotted, and the mycPLD2 levels were determined with anti-myc antibody. An anti-myc immunoblot of whole-COS-7 lysates overexpressing mycPLD2 WT, Y169F, Y179F and Y169/ 179F mutants is shown. Anti-myc and anti-Grb2 immunoblots of whole-COS-7 lysates are also shown.
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The PLD2 residue Y 179 is negatively involved in Ras activation The next question that needed to be addressed was what physiological effect the PLD2/Grb2/Sos complex might accomplish in the cell. It is well known that Grb2/Sos regulates Ras activation (Egan et al., 1993; Li et al., 2001 ). Transfection of COS-7 cells with mycPLD2 Y179F, but not with WT or Y169F, resulted in Ras activation (Figure 8a ). This indicates that the complex Interaction of PLD2 inactive mutants with Grb2 in vivo. COS-7 lysates from cells transiently expressing mycPLD2 K444R, K758R or K444/758R were immunoprecipitated with either anti-myc or anti-Grb2 antibodies. Immunoprecipitates were separated by SDS-PAGE and immunoblotted with anti-myc. Transfected COS-7 whole-cell lysates were also probed with anti-myc antibody (bottom panel).
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PLD2-Y 169
/Grb2/Sos is capable of stimulating Ras when the Y 179 site is removed. As known, activation of Ras via the Grb2/Sos complex can engage cellular proliferation through mitogenic signaling cascades (Li et al., 1993; Kyriakis and Avruch, 2001 ). To test for a possible functional role of PLD2 on cellular proliferation, we studied Erk activation (as phosphorylation of p44/42 Erk ), commitment of cells to undergo S phase of the cell cycle (as upregulation of the proliferating cell nuclear antigen (PCNA)) and de novo DNA synthesis (as 
Discussion
The data presented here identify for the first time two neighboring tyrosines, Y 169 and Y 179 , in the PLD2 molecule as being essential for the Grb2/PLD2 interaction that our laboratory has described recently (Horn et al., 2005) . The amino acids Y 169 and Y 179 in PLD2 are expressed within the context of perfect matches for SH2-mediated Grb2 interaction (pYxNx) (Songyang et al., 1993 (Songyang et al., , 1994 . Pull-down assays using GSTGrb2 WT and a SH2-deficient mutant of Grb2 (R86K) demonstrate that the SH2 domain of Grb2 especificaly binds PLD2 in vitro. Molecular analysis of the interaction between endogenous Grb2 and PLD2 mutants revealed that (Park et al., 2000; Kim et al., 2002; Ahn et al., 2003; Jang et al., 2003) . The relevance of the PX domain is illustrated by the fact that its deletion from PLD2 produces a catalytically inactive enzyme in vitro (Sung et al., 1999; Park et al., 2000) . However, the specificity of some PX-interactions to PLD2, but not other PX-containing proteins, raises the possibility that extra sequence determinants are dictating protein-protein interactions. Our discovery of the neighboring tyrosines Y 169 and Y 179 fills this gap. The physiological relevance of PLD2-Y 169 in PLD2 high basal activity is highlighted by the fact that mycPLD2 Y179F (and DY
179
, result not shown), otherwise a fully active enzyme, decreased its PLD activity by B70% in the presence of competing amounts of purified GSTGrb2 P49/206L, an SH3-deficient mutant of Grb2 (Figure 5c ). Consequently, we can draw the following three conclusions: (i) the SH2 domain of Grb2 binds PLD2-Y 169 ; (ii) PLD2-Y 169 / Grb2 interaction is linked to high basal PLD2 activity, and (iii) the SH3 domains of Grb2 are involved in the regulation of PLD2 activity.
Considering that substrate binding via the SH2 domain of Grb2 requires a phosphorylated tyrosine (pYxNx) (Songyang et al., 1993 (Songyang et al., , 1994 , residues Y 169 and Y 179 appear to be phosphorylated in vivo by as-yet unknown mechanisms. In addition, Y 169 and Y 179 may be constitutively phosphorylated by mechanisms independent of PA and its metabolites since PLD2 activity is not necessary for Grb2 binding in vivo.
As for the correlation between PLD2 and tyrosine phosphorylation, it has been previously shown that PLD2 interacts with c-Src and other tyrosine kinases (Slaaby et al., 1998; Ahn et al., 2003; Choi et al., 2004) , and the protein tyrosine phosphatase 1b (PTP1b) (Horn et al., 2005) . Since the ternary complex PLD2/Grb2/ PTP1b exists in vivo (Horn et al., 2005) , it is possible that total tyrosine phosphorylation of PLD2 may also be regulated in a PLD2-Y 179 /Grb2-SH3-dependent manner. Supporting this notion is that mycPLD2 Y179F and DY 179 are hypophosphorylated proteins in vivo. The SH3 domains of Grb2 interact with the Cterminal proline-rich domain of the Ras guaninenucleotide exchange factor, Sos . As presented in Figure 7 . It is well known that upon mitogenic stimulation, the Grb2/Sos complex increases Ras-mediated cell proliferation (Egan et al., 1993; Li et al., 1993) . A role for PLD2 in cell proliferation is suggested by several reports showing that PLD activity is elevated in response to growth factors and oncogenes (reviewed in Foster and Xu (2003) ). Data in Figure 8 (Liu et al., 2002) . As known, the PI3K/Akt cell survival pathway can be activated by Ras, as well as by PLD2 (Banno et al., 2005) .
In conclusion, we have shown here that PLD2 is associated with Grb2 and Sos in vivo through PLD2 residues Y 169 and Y
. Furthermore, Y 169 and Y 179 are functionally nonequivalent, despite their role in Grb2/ Sos recruitment. While Y 179 regulates total tyrosine phosphorylation of the protein, we propose that PLD2 residue Y 169 is involved in PLD2's catalysis and Ras/ Erk-mediated cell proliferation via Grb2 recruitment and Grb2/Sos engagement, respectively. The elucidation of two neighboring tyrosines with distinct functionalities will undoubtedly help us understand the signal mechanisms followed by PLD2 in the cell.
Materials and methods
Plasmids
The expression construct containing the full cDNA of human Grb2 variant 1 cDNA (pCMV6-Grb2, OriGene Technologies) was the template for PCR subcloning. The Grb2 ORF was PCR-amplified using the sense (EcoRI) primer 5 0 -CAC TGA GCA GAA TTC AGA ATG GAA GCC ATG GCC-3 0 and the antisense (PspOMI) primer 5 0 -TTA AAT CCA ACG GGC CCT CCC ACC CCC TAA-3 0 . The PCR product was EcoRI/ PspOMI-digested, purified and C-terminally subcloned into the EcoRI/NotI-digested Xpress-tagged pcDNA3.1/HisC expression vector (Invitrogen, Carlsbald, CA, USA). The pcDNAXGrb2 obtained was BamHI/XhoI-digested and the Grb2 insert was N-terminally subcloned in-frame into the glutathione S-transferase (GST)/IPTG-inducible prokaryotic expression vector pGEX-4T1 (Amersham). Molecular identities of pcDNA-XGrb2 and pGEX-GSTGrb2 were corroborated by direct nucleotide sequencing (Cleveland Genomics, Cleveland, OH, USA).
Mutagenesis of pcDNA-mycPLD2 and pGEX-GSTGrb2
The pcDNA-mycPLD2 construct (Lopez et al, 1998) 0 -GAT GGG GCC TTT CTT ATA AAA GAG AGT GAG AGC GCT C-3 0 , Grb2 P49L sense 5 0 -TT AAT GGA AAA GAC GGC TTC ATT CTG AAG AAC TAC ATA GAA ATG AAA CCA C-3 0 and Grb2 P206L sense 5 0 -G CAG ACC GGC ATG TTT CTG CGC AAT TAT GTC ACC C-3 0 (all oligos and their reverse complements were PAGE/ HPLC purified, Integrated DNA Technologies, Coralville, IA, USA). Molecular identity of pcDNA-mycPLD2 and pGEXGSTGrb2 mutants were corroborated by PCR, restriction digestion and direct sequence analysis (Cleveland Genomics, Cleveland, OH, USA).
In vitro GST-fusion protein pull-down assay pGEX-GST (vector alone) and pGEX-GSTGrb2 were used to transform Escherichia coli BL12 cells following standard procedures. GSTGrb2 fusion proteins and GST protein alone were harvested by sonication and purified with glutathioneSepharose 4B beads following the manufacturer's instructions. Protein purity was estimated on a 4-20% SDS-PAGE gel. For in vitro binding studies, COS-7 cells transiently expressing pcDNA-mycPLD2, were lysed in lysis buffer (5 mM HEPES, 1 mM leupeptin, 768 nM aprotinin, 100 mM sodium orthovanadate and 0.5% Triton X-100). After centrifugation, aliquots of the supernatant were cleared and incubated with purified GSTGrb2 (1.5 mg) or the SH2-deficient mutant R86K (5 mg) fusion proteins. The GSTGrb2/mycPLD2 complexes were pulled down as follows: cleared lysates (20-40 mg) were incubated with GST-fusion proteins (or 5 mg GST alone) and glutathione-Sepharose 4B beads in a final volume of 400 ml of lysis buffer for 1 h at 251C. Protein complexes were collected by centrifugation and washed two times with lysis buffer. Bead-associated protein complexes were either resolved by SDS-PAGE and transferred to a PVDF membrane, followed by immunoblot analysis with anti-myc or GST antibodies, or they were incubated again with an excess amount of purified Grb2 (1-5 mg) for 1 h for the competition assay.
Transient transfection of COS-7 cells COS-7 were initially seeded at 1 Â 10 5 cells/well in six-well tissue culture plates, in 2 ml D-MEM containing 10% FBS and nonessential amino acids. Cells were grown at 371C in a CO 2 incubator until the cells were 70-80% confluent (B30 h). Transfection was performed as described previously utilizing lipofectamine as the DNA carrier (Horn et al., 2005) .
Immunoprecipitation and immunoblotting
Immunoprecipitation with specific antibodies and immunoblotting were performed following procedures already published Lehman et al., 2003) .
In vitro PLD assay PLD activity (transphosphatidylation) in cell sonicates was measured in liposomes of shortchain PC, 1,2dioctanoylsngly-cero-3-phosphocholine (PC8), and [ 3 H]butanol (Horn et al., 2001) . Between 40-60 mg of cell sonicates were added to 1.5 ml microfuge Eppendorf tubes containing the following assay mix (120 ml final volume): 3.5 mM PC8 phospholipid, 1 mM PIP 2 , 75 mM HEPES, pH 7.9, and 2.3 mCi (4 mM) [ 3 H]butanol. When analyzing the role of Y 169 in PLD activity, 10 mg GSTGrb2 WT or 10-20 mg GSTGrb2 P49/206L were added to the reaction media. The mixture was incubated for 20 min at 301C and the reaction was stopped by adding 300 ml ice-cold chloroform/ methanol (1:2) and 70 ml of 1% perchloric acid. The tubes were then vortexed and 100 ml of 1% perchloric acid and 100 ml of chloroform were added, vortexed again, centrifuged, and the upper phase was aspirated. The lower phase was washed once with 100 ml 1% perchloric acid, an aliquot of 125 ml was removed, and dried for thin layer chromatography (TLC). TLC lanes that migrated as authentic PBut were scraped, dissolved in 3 ml of Scintiverse II scintillation cocktail and counted. Background counts (from boiled samples) were subtracted from experimental samples.
at room temperature for 5 min. Precipitated cellular DNA was washed two times with 5% TCA and solubilized by adding 550 ml/well of 12.5 N NaOH. Precipitable [ 3 H]DNA was measured by scintillation counting.
Statistical analysis
The analysis of multiple intergroup differences in each experiment was conducted by one-way analysis of variance followed by Student's t-test. A Po0.05 was used as the criterion of statistical significance.
